A computational approach predicting CYP450 metabolism and estrogenic activity of an endocrine disrupting compound (PCB-30).

作者: Alice C. Layton , Jerome Baudry , Jason B. Harris , Melanie L. Eldridge , Gary Sayler

DOI: 10.1002/ETC.2595

关键词:

摘要: Endocrine disrupting chemicals influence growth and development through interactions with the hormone system, often binding to receptors such as estrogen receptor. Computational methods can predict endocrine chemical activity of unmodified compounds, but approaches predicting following metabolism are lacking. The present study uses a well-known environmental contaminant, PCB-30 (2,4,6-trichlorobiphenyl), prototype integrates predictive (computational) experimental determine its metabolic transformation by cytochrome P450 3A4 (CYP3A4) 2D6 (CYP2D6) into estrogenic byproducts. predictions suggest that hydroxylation occurs at 3- or 4-phenol positions leads metabolites bind more strongly than parent molecule human receptor alpha (hER-α). Gas chromatography–mass spectrometry experiments confirmed primary metabolite for CYP3A4 CYP2D6 is 4-hydroxy-PCB-30, secondary 3-hydroxy-PCB-30. Cell-based bioassays (bioluminescent yeast expressing hER-α) hydroxylated PCB-30. These results support applied model's ability fate PCB-30, which could be used identify other involved in similar pathways. Environ Toxicol Chem 2014;33:1615–1623. © 2014 SETAC

参考文章(55)
Angelika Beyer, Marek Biziuk, Environmental fate and global distribution of polychlorinated biphenyls. Reviews of Environmental Contamination and Toxicology. ,vol. 201, pp. 137- 158 ,(2009) , 10.1007/978-1-4419-0032-6_5
Nina Isoherranen, Brooke M. VandenBrink, The role of metabolites in predicting drug-drug interactions: focus on irreversible cytochrome P450 inhibition. Current Opinion in Drug Discovery & Development. ,vol. 13, pp. 66- 77 ,(2010)
David Kupfer, Shangara S. Dehal, CYP2D6 catalyzes tamoxifen 4-hydroxylation in human liver. Cancer Research. ,vol. 57, pp. 3402- 3406 ,(1997)
Sally R. Ellingson, Jeremy C. Smith, Jerome Baudry, VinaMPI: Facilitating multiple receptor high-throughput virtual docking on high-performance computers Journal of Computational Chemistry. ,vol. 34, pp. 2212- 2221 ,(2013) , 10.1002/JCC.23367
Zeruesenay Desta, Bryan A. Ward, Nadia V. Soukhova, David A. Flockhart, Comprehensive evaluation of tamoxifen sequential biotransformation by the human cytochrome P450 system in vitro: prominent roles for CYP3A and CYP2D6. Journal of Pharmacology and Experimental Therapeutics. ,vol. 310, pp. 1062- 1075 ,(2004) , 10.1124/JPET.104.065607
Alice C. Layton, John Sanseverino, Betsy W. Gregory, James P. Easter, Gary S. Sayler, T.Wayne Schultz, In vitro estrogen receptor binding of PCBs: measured activity and detection of hydroxylated metabolites in a recombinant yeast assay. Toxicology and Applied Pharmacology. ,vol. 180, pp. 157- 163 ,(2002) , 10.1006/TAAP.2002.9395
Shigeyuki Kitamura, Yuri Shimizu, Yuko Shiraga, Mayumi Yoshida, Kazumi Sugihara, Shigeru Ohta, Reductive Metabolism ofp,p′-DDT ando,p′-DDT by Rat Liver Cytochrome P450 Drug Metabolism and Disposition. ,vol. 30, pp. 113- 118 ,(2002) , 10.1124/DMD.30.2.113
Patrik Rydberg, David E. Gloriam, Jed Zaretzki, Curt Breneman, Lars Olsen, SMARTCyp: A 2D Method for Prediction of Cytochrome P450-Mediated Drug Metabolism ACS Medicinal Chemistry Letters. ,vol. 1, pp. 96- 100 ,(2010) , 10.1021/ML100016X
D J Svendsgaard, T R Ward, H A Tilson, P R Kodavanti, Empirical modeling of an in vitro activity of polychlorinated biphenyl congeners and mixtures. Environmental Health Perspectives. ,vol. 105, pp. 1106- 1115 ,(1997) , 10.1289/EHP.971051106
David W. Borhani, David E. Shaw, The future of molecular dynamics simulations in drug discovery. Journal of Computer-aided Molecular Design. ,vol. 26, pp. 15- 26 ,(2012) , 10.1007/S10822-011-9517-Y